UW-Madison launches Microbiome Initiative
We are not alone. Each of us carries a wide array of microbial species that outnumber our cells by ten-fold. Recent studies have shown that the complement of microorganisms, the microbiome, is an important determinant of human health and disease. The microbiomes of other animals, plants, soil, bodies of water, and the atmosphere play similarly important roles.
Our understanding of the diversity and roles of these microbiomes is limited, a fact that led the White House Office of Science and Technology Policy to launch the National Microbiome Initiative (NMI) last year. Stakeholders, including UW-Madison, have responded with new commitments to develop a comprehensive understanding of microbiomes across all ecosystems.
UW-Madison’s Microbiome Initiative comes with $1 million in grant funding administered by the Vice Chancellor for Research and Graduate Education to support interdisciplinary research, infrastructure, and research community enhancements related to the microbiome.
To read the full press release go here.
A phase one clinical trial to test a potential new Ebola vaccine developed by researchers at the University of Wisconsin–Madison is underway in Japan.
The University of Wisconsin–Madison requires faculty, staff, students, contractors, and affiliates seeking to use autonomous vehicles, including unmanned aircraft systems (drones), for UW-related education, research, and non-academic purposes are now asked to…
A 15-member search-and-screen committee, chaired by Professor of Biomedical Engineering Bill Murphy, will conduct a nationwide search.
News and Announcements
UW Research at a Glance
in nation for volume of research
spent on research
VCRGE research and service centers